Horizon Therapeutics plc Launches The Horizon Prize with Massachusetts Institute of Technology (MIT) Solve to Advance Solutions for the Rare Disease Community
Go back to Horizon Therapeutics plc Launches The Horizon Prize with Massachusetts Institute of Technology (MIT) Solve to Advance Solutions for the Rare Disease Community| National Health Partners, Inc. (NYSE: HPR) | Delayed: 4.73 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.73 | 52 Week High | $0.28 | |||
| Open | $3.62 | 52 Week Low | $0.25 | |||
| Day High | $4.73 | P/E | N/A | |||
| Day Low | $4.73 | EPS | $-0.23 | |||
| Volume | 3,248 | |||||
| HORIZON PHARMA (NASDAQ: HZNP) | Delayed: 116.30 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $116.30 | 52 Week High | $23.44 | |||
| Open | $116.30 | 52 Week Low | $13.06 | |||
| Day High | $116.30 | P/E | N/A | |||
| Day Low | $116.30 | EPS | $-0.96 | |||
| Volume | 294,489 | |||||
